In a first for Europe, the Cliniques Saint-Luc have carried out a groundbreaking neurosurgical procedure, marking a new milestone in the management of refractory epilepsy.
A new clinical study by the Brussels-based Jules Bordet institute may have found a new way to make certain breast cancer tumours more sensitive to immunotherapy.